Synchem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.13 M
- Company Age 24 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.14 Cr
About Synchem Pharmaceuticals
Synchem Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 April 2000 and has a history of 24 years and nine months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.13 M.
The company currently has active open charges totaling ₹2.14 Cr.
Dharmendra Jain, Manish Jain, and Dinesh Jain serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239MP2000PTC051978
-
Company No.
126020
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 2000
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
What products or services does Synchem Pharmaceuticals Private Limited offer?
Synchem Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Tablets, Pharmaceutical Syrup, Ayurvedic Herbal Syrups & Tonics, Pharmaceutical Medicine, Pharmaceutical Drug, Dry Syrups, Antihistamines, Anti Cold Tablet, Antibiotic Tablets & Capsules, Cefixime Tablet.
Who are the key members and board of directors at Synchem Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendra Jain
|
Managing Director | 19-Apr-2000 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Manish Jain
|
Whole-Time Director | 01-Jun-2007 | Current |
|
Dinesh Jain
|
Whole-Time Director | 19-Apr-2000 | Current |
Financial Performance of Synchem Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synchem Pharmaceuticals?
Unlock access to Synchem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹21.40 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.24 Cr
- Axis Bank Limited : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2021 | Axis Bank Limited | ₹9.00 M | Open |
| 30 Mar 2016 | State Bank Of India | ₹1.00 Cr | Open |
| 22 Apr 2002 | State Bank Of India | ₹2.40 M | Open |
How Many Employees Work at Synchem Pharmaceuticals?
Unlock and access historical data on people associated with Synchem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synchem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synchem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.